eli lilly and company zepbound - Search News

Eli Lilly unveils $27bn US investment

CNN on MSN · 3h

Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffs

Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the United States, shoring up domestic manufacturing as President Donald Trump threatens new tariffs on pharmaceuticals.

The Financial Times · 3h

Eli Lilly unveils $27bn US investment as corporate America seeks to woo Trump

Eli Lilly has unveiled a $27bn investment in US manufacturing facilities as the pharmaceutical industry prepares for the threat of tariffs and mounts a charm offensive aimed at President Donald Trump’s new administration.

CNBC on MSN · 1h

Eli Lilly CEO on $27 billion investment in U.S. manufacturing expansion

CNBC’s Angelica Peebles and Eli Lilly CEO David Ricks, join 'Squawk on the Street' to discuss the company's U.S. manufacturing sites expansion, tariffs and domestic jobs.

Eli Lilly announces $27 billion investment in U.S. drug manufacturing sites

Eli Lilly plans to spend $27 billion to build new drug manufacturing sites in the U.S., at a time when President Trump is seeking to press drugmakers to move stateside.

Eli Lilly is offering weight loss drug Zepbound

Hosted on MSN · 21h

Eli Lilly cuts prices for Zepbound weight-loss drug again

Pharmaceutical giant Eli Lilly is once again expanding the supply of its weight-loss drug Zepbound and cutting the cost for patients that don't have insurance.

The Wall Street Journal on MSN · 20h

Eli Lilly to Offer Higher Doses of Obesity Drug Zepbound at Discounted Prices

Eli Lilly said it has launched new doses of its obesity treatment drug and reduced its prices.

Eli Lilly to lower price of Zepbound vials, offer more doses

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells.

BioPharma Dive3h

Lilly expands US manufacturing build-out with $50B target

The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...

1h

InnovationRx: Eli Lilly Has Stockpiled Nearly $550 Million Of Its Next Obesity Drug

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...

1h

Eli Lilly to build 4 more manufacturing sites in US

Eli Lilly ( LLY) announced Wednesday that it is ramping up US manufacturing, adding four new sites to help increase the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results